HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$19.15
Day range
$17.77 - $18.89
Year range
$11.40 - $27.20
Market cap
1.44B USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 86.00K | 19.44% |
Operating expense | 83.57M | 62.91% |
Net income | -76.69M | -60.91% |
Net profit margin | -89.17K | -34.71% |
Earnings per share | -1.15 | -5.50% |
EBITDA | -83.35M | -63.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 753.24M | 140.65% |
Total assets | 771.90M | 134.79% |
Total liabilities | 64.40M | 42.55% |
Total equity | 707.50M | — |
Shares outstanding | 79.21M | — |
Price to book | 2.92 | — |
Return on assets | -30.75% | — |
Return on capital | -32.54% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -76.69M | -60.91% |
Cash from operations | -67.71M | -73.68% |
Cash from investing | -84.67M | -276.24% |
Cash from financing | 245.02M | 1,485.19% |
Net change in cash | 92.65M | 277.93% |
Free cash flow | -39.47M | -75.02% |
About
Founded
2010
Headquarters
Website
Employees
96
